Skip to content

MARKETS

S&P 5007,718.60−0.38%

NASDAQ 10029,544.15+0.21%

XBI163.81−0.35%

IBB211.92−0.88%

DOW 3053,414.25−0.51%

FTSE 10010,831.09−0.00%

Search

Loading index…

The Biotech Brief

Trial results, FDA catalysts and deal flow, decoded — in your inbox before the open.

Free. Unsubscribe any time.

Market Overview

SAT SEP 5 2026 · MIAMI

Trending Now

Trending now LIVE

1NDAQNasdaq, Inc. - Common StockBullish150
2TGTTarget Corporation Common StockBullish40
3PPLIPeople Incorporated - Common StockNeutral37
4NVDANVIDIA Corporation - Common StockBearish33
5NILISurge Battery Metals Inc.Neutral31

Powered by Eagle Eye See the board →

Discussion data, informational only. Not investment advice.

The Latest

Ultragenyx Angelman Failure Turns an Approval Year Into Cost Cuts
Sep 5 · 20:24 ET
GSK Pays Hutchmed $110 Million for KRAS-EGFR Conjugate
Sep 5 · 17:52 ET
FDA's TEMPO Pilot Lets AI Devices Reach Patients Pre-Clearance
Sep 5 · 16:05 ET
Superluminal Raises $60 Million to Take MC4R Obesity Drug Into Phase 1
Sep 5 · 14:53 ET
Abivax Stays Single While Biotech M&A Runs Hot
Sep 5 · 13:44 ET
Cityblock's $116 Million Raise Fits Digital Health's Megaround Habit
Sep 5 · 12:41 ET